R & D

The link you have chosen leads to a site maintained by a third party over whom Bracco Imaging has no control. As such, Bracco Imaging makes no representation as to the accuracy or any other aspect of the information on this site. The clinical use of Bracco Imaging Products in these pages may not be consistent with the approved indications.

The information on this site is not country specific and may contain information that is outside the approved indication where you practice.

Bracco Imaging R&D objectives

Cardiovascular disease: identification of patients at risk due to the presence of unstable plaque and ability to monitor response to treatment;

Oncology: targeted agents to visualise and characterise angiogenesis in order to identify and monitor patients responding to novel anti-angiogenic therapies;

Degenerative diseases: agents able to visualise and characterise disease progression to enable medical doctors to monitor response to treatment.

Our main R&D Targets

We aim to provide Integrated Imaging Solutions to the Healthcare Community for Global Patient Management.

Our main R&D targets are:

To improve Patient Management in the above areas through Functional Imaging and/or Molecular Imaging with the goal of supporting medical doctors in the selection and modulation of targeted therapies guiding them in their interventions with minimally invasive techniques;

To develop New Business Patient Management Solutions with novel Information Technology tools for mining & handling Imaging & Patient Data so as to provide: